FANG; Qun Kevin

Patent Applications and Registrations

Patent applications and USPTO patent grants for FANG; Qun Kevin.The latest application filed is for "treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine".

Company Profile

4.26.33

FANG; Qun Kevin - Wellesley MA
FANG; Qun Kevin - Wallesley MA
Fang; Qun Kevin - Wellesly MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE App 20210046021 - JERUSSI; Thomas ; et al.	2021-02-18
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Grant 10,702,486 - Jerussi , et al.	2020-07-07
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE App 20200000746 - JERUSSI; Thomas ; et al.	2020-01-02
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Grant 10,328,036 - Jerussi , et al.	2019-06-25
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE App 20180333373 - Jerussi; Thomas ; et al.	2018-11-22
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Grant 9,907,764 - Jerussi , et al. March 6, 2	2018-03-06
Heterocyclic compounds and methods of use thereof Grant 9,884,844 - Fang , et al. February 6, 2	2018-02-06
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE App 20170157067 - JERUSSI; Thomas ; et al.	2017-06-08
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Grant 9,498,452 - Jerussi , et al. November 22, 2	2016-11-22
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE App 20160136111 - Jerussi; Thomas ; et al.	2016-05-19
Heterocyclic Compounds And Methods Of Use Thereof App 20150336928 - FANG; Qun Kevin ; et al.	2015-11-26
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Grant 9,072,699 - Jerussi , et al. July 7, 2	2015-07-07
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE App 20140128474 - JERUSSI; Thomas ; et al.	2014-05-08
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Grant 8,658,700 - Jerussi , et al. February 25, 2	2014-02-25
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS App 20130289013 - FANG; Qun Kevin ; et al.	2013-10-31
Imidazo[1,2-a]pyridine compounds Grant 8,497,278 - Fang , et al. July 30, 2	2013-07-30
Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20130158125 - Jerussi; Thomas ; et al.	2013-06-20
Histamine H3 inverse agonists and antagonists and methods of use thereof Grant 8,404,670 - Chytil , et al. March 26, 2	2013-03-26
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Grant 8,344,030 - Jerussi , et al. January 1, 2	2013-01-01
Histamine H3 Inverse Agonists And Antagonists And Methods Of Use Thereof App 20120172350 - Chytil; Milan ; et al.	2012-07-05
Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20120136065 - JERUSSI; Thomas P. ; et al.	2012-05-31
Histamine H3 Inverse Agonists And Antagonists And Methods Of Use Thereof App 20120077802 - Chytil; Milan ; et al.	2012-03-29
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Grant 8,134,029 - Jerussi , et al. March 13, 2	2012-03-13
Histamine H3 Inverse Agonists And Antagonists And Methods Of Use Thereof App 20120022050 - Chytil; Milan ; et al.	2012-01-26
Histamine H3 inverse agonists and antagonists and methods of use thereof Grant 8,063,032 - Chytil , et al. November 22, 2	2011-11-22
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS App 20110166146 - Fang; Qun Kevin ; et al.	2011-07-07
Histamine H3 Inverse Agonists and Antagonists and Methods of Use Thereof App 20110065694 - Chytil; Milan ; et al.	2011-03-17
Inhibitors of D-amino acid oxidase Grant 7,902,252 - Heffernan , et al. March 8, 2	2011-03-08
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20100292340 - JERUSSI; Thomas P. ; et al.	2010-11-18
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Grant 7,790,772 - Jerussi , et al. September 7, 2	2010-09-07
Histamine H3 Inverse Agonists And Antagonists And Methods Of Use Thereof App 20100204214 - Chytil; Milan ; et al.	2010-08-12
Fused Heterocycles App 20100029741 - Dorsey; James M. ; et al.	2010-02-04
Inhibitors Of D-amino Acid Oxidase App 20100029737 - Heffernan; Michele L. R. ; et al.	2010-02-04
Fused Heterocycles App 20100022612 - Dorsey; James M. ; et al.	2010-01-28
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20090292026 - Jerussi; Thomas P. ; et al.	2009-11-26
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Grant 7,589,237 - Jerussi , et al. September 15, 2	2009-09-15
Fused heterocycles Grant 7,579,370 - Heffernan , et al. August 25, 2	2009-08-25
Inhibitors Of D-amino Acid Oxidase App 20090099248 - Heffernan; Michele L. R. ; et al.	2009-04-16
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20080280993 - Jerussi; Thomas P. ; et al.	2008-11-13
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Grant 7,423,179 - Jerussi , et al. September 9, 2	2008-09-09
Fused heterocyclic inhibitors of D-amino acid oxidase App 20080058395 - Heffernan; Michele L. R. ; et al.	2008-03-06
Fused Heterocycles App 20080004328 - Dorsey; James M. ; et al.	2008-01-03
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide App 20060216799 - Jerussi; Thomas P. ; et al.	2006-09-28
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Grant 7,105,699 - Jerussi , et al. September 12, 2	2006-09-12
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Grant 7,087,785 - Jerussi , et al. August 8, 2	2006-08-08
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide App 20060128993 - Jerussi; Thomas P. ; et al.	2006-06-15
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide App 20060014982 - Jerussi; Thomas P. ; et al.	2006-01-19
Methods of treating or preventing pain using sibutramine metabolites Grant 6,974,838 - Senanayake , et al. December 13, 2	2005-12-13
Methods of treating or preventing pain using sibutramine metabolites App 20040180857 - Senanayake, Chrisantha Hugh ; et al.	2004-09-16
Tramadol analogs and uses thereof Grant 6,780,891 - Senanayake , et al. August 24, 2	2004-08-24
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetra- hydro-1-napthalenamine and its formamide App 20040092605 - Jerussi, Thomas P. ; et al.	2004-05-13
Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetr- ahydro-N-methyl-1-napthalenamine App 20040087661 - Jerussi, Thomas P. ; et al.	2004-05-06
Methods of treating or preventing neuropathic pain using sibutramine metabolites Grant 6,710,087 - Senanayake , et al. March 23, 2	2004-03-23
Tramadol analogs and uses thereof App 20030171440 - Senanayake, Chris Hugh ; et al.	2003-09-11
Compositions comprising dopamine reuptake inhibitors and methods of making and using the same App 20020183281 - Senanayake, Chrisantha Hugh ; et al.	2002-12-05
Bupropion metabolites and methods of use Grant 6,337,328 - Fang , et al. January 8, 2	2002-01-08
Synthesis of terfenadine and derivatives Grant 5,925,761 - Senanayake , et al. July 20, 1	1999-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.